Eliem Therapeutics Inc (ELYM) stock is down -19.47% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ELYM stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 11. ELYM's rank also includes a long-term technical score of 18.
ELYM has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ELYM!
Eliem Therapeutics Inc (ELYM) stock is up 7.86% while the S&P 500 is down -0.49% as of 10:39 AM on Thursday, Jul 20. ELYM has risen $0.22 from the previous closing price of $2.80 on volume of 983,648 shares. Over the past year the S&P 500 is up 14.73% while ELYM is down -19.47%. ELYM lost -$2.06 per share in the over the last 12 months.
Click Here to get the full Stock Report for Eliem Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
